PRECISIONBIOLOGICS
Menu
↗
Regulatory

Homologous use and when to call clinic counsel

Why homologous use sits at the center of many HCT/P reviews and how procurement teams should escalate without practicing law.

Reviewed 2026-10-27

Plain-language definition

Homologous use generally means the product performs the same basic function in the recipient as in the donor. Applying that definition is a counsel-level analysis.

Purchasing can collect supplier framing but should not finalize the determination.

Red flags for escalation

Marketing that suggests systemic disease treatment, broad regenerative cure language, or uses far from the tissue's basic function should trigger counsel review.

Keep counsel memos with the SKU file and revisit if labeling or intended use changes.

Filing and retention

Store evidence with the lot file and note the lab name and test date when provided.

Save guidance document version dates in your regulatory library.

Operational checklist for homologous use clinic counsel

Before ordering under the topic homologous use clinic counsel, confirm storage class, receiving owner, and which documents will be required at release.

Close open items in writing. Do not infer missing COA fields from a different lot or SKU.

FAQ

Frequently asked questions

Does Precision Biologics certify regulatory status for our use?+

No. Classification and intended-use determinations belong to the ordering physician and clinic counsel.

Is this legal advice?+

No. This is general information for licensed healthcare professionals.

Can account approval replace counsel review?+

No. Account verification is administrative only.

Does this page determine how we may use products discussed under homologous use clinic counsel?+

No. Intended use remains with the ordering physician and clinic counsel.

Sources

  1. 21 CFR Part 1271 ↗eCFR
  2. FDA: Minimal Manipulation and Homologous Use guidance ↗FDA
  3. HCT/P Small Entity Compliance Guide ↗FDA